Leipzig, Germany

Vice President, Operations – Europe ; Managing Director – Velocity Clinical Research, Leipzig GmbH
Sandra Stark, PhD joined Velocity Clinical Research after 18 years at Parexel where she held various positions in Project Management, Business Development, and Portfolio Management. After leading the Therapeutic Area of Immunology and Rare Diseases in Early Phase for seven years, she took on the role of Unit Head of Parexel’s Phase 1 unit in Berlin, Germany – a 120-bed Clinical Pharmacology clinic. Moving from the Sponsor/CRO side of clinical research to Velocity Clinical Research not only closes the loop full circle, it expands her experience into late-stage development. Dr. Stark brings over 20 years of experience in both the CRO and biopharmaceutical industry, with extensive knowledge in Early Drug Development, Translational Medicine, Pre-clinical, and thorough strategic development, to her roles with Velocity, focusing on fast and efficient POC to support go/no-go decisions for late-stage development. Dr. Stark holds a Diploma in Biology from Kassel University and a PhD in Immunology and Immunogenetics from University of Göttingen.

Principal Investigator
Kai Mehltretter, MD is a highly experienced and qualified investigator with over 20 years of experience in the field of clinical research. He currently works as a freelance Principal Investigator at Velocity Clinical Research Leipzig GmbH, and as a freelance Pharmacovigilance Consultant. Before joining the SIBAmed/Velocity team, he was a consulting physician for major pharmaceutical companies and Head of a CRO’s Pharmacovigilance Department at IST GmbH Mannheim. Dr. Mehltretter has also held roles in various organisations, including Team-Lead Investigator for Phase 1-2 clinical studies at IKP GmbH Grünstadt and CRS Clinical Research Services Mannheim GmbH, as a Freelance Clinical Investigator and Consultant at Abbott GmbH & Co KG Ludwigshafen, and as an Assistant Physician at the Ophthalmic Clinic at Ruprecht-Karls-University Heidelberg. Dr. Mehltretter is highly educated and holds a medical degree from Ruprecht-Karls-University Heidelberg. He has authored publications in the fields of Ophthalmology and Pharmacokinetics/Pharmacodynamics.

Principal Investigator
Thomas Müller, MD is a specialist in Paediatrics working as a Principal Investigator and Specialist at Velocity Clinical Research Leipzig GmbH and previously at SIBAmed Study Center in Leipzig, Germany. In parallel, he works as a paediatrician in the Leipzig Family Medicine practice FMZ Radowsky. He has also worked as a Medical Specialist for paediatrics with psychiatric/neurological disorders at the Helios Clinic Social Paediatrics center in Leipzig. Dr. Müller has over a decade of experience in the field, having served as a Resident in paediatric medicine at Helios Clinic and as a Resident in internal and general medicine at DIAKOMED – Diakonie Hospital.